Yang Z - Search Results

1

Tumor-Infiltrating PD-1^hiCD8⁺-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers.

Yang Z, Deng Y, Cheng J, Wei S, Luo H, Liu L. Yang Z, et al. Front Oncol. 2021 Sep 15;11:695006. doi: 10.3389/fonc.2021.695006. eCollection 2021. Front Oncol. 2021. PMID: 34604032 Free PMC article.

2

Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis of 13 studies.

Li C, Wu W, Chen N, Song H, Lu T, Yang Z, Wang Z, Zhou J, Liu L. Li C, et al. Among authors: yang z. J Thorac Dis. 2017 Dec;9(12):5322-5334. doi: 10.21037/jtd.2017.12.72. J Thorac Dis. 2017. PMID: 29312742 Free PMC article.

3

Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer: A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis.

Wei S, Guo C, He J, Tan Q, Mei J, Yang Z, Liu C, Pu Q, Ma L, Yuan Y, Lin F, Zhu Y, Liao H, Wang W, Liu Z, Li Q, Jiang B, Li C, Xia L, Zhao K, Gan F, Cheng J, Wu Z, Wang Y, Lin Y, Kou Y, Che G, Chen L, Li J, Liu L. Wei S, et al. Among authors: yang z. JAMA Surg. 2019 Jul 1;154(7):e190972. doi: 10.1001/jamasurg.2019.0972. Epub 2019 Jul 17. JAMA Surg. 2019. PMID: 31042283 Free PMC article. Clinical Trial.

4

Long-term survival outcomes of video-assisted thoracic surgery lobectomy for stage I-II non-small cell lung cancer are more favorable than thoracotomy: a propensity score-matched analysis from a high-volume center in China.

Mei J, Guo C, Xia L, Liao H, Pu Q, Ma L, Liu C, Zhu Y, Lin F, Yang Z, Zhao K, Che G, Liu L. Mei J, et al. Among authors: yang z. Transl Lung Cancer Res. 2019 Apr;8(2):155-166. doi: 10.21037/tlcr.2018.12.04. Transl Lung Cancer Res. 2019. PMID: 31106126 Free PMC article.

5

Decreased expression of EFCC1 and its prognostic value in lung adenocarcinoma.

Xia L, Zhu Y, Zhang C, Deng S, Deng Y, Yang Z, Mei J, Liu L. Xia L, et al. Among authors: yang z. Ann Transl Med. 2019 Nov;7(22):672. doi: 10.21037/atm.2019.10.41. Ann Transl Med. 2019. PMID: 31930073 Free PMC article.

6

[Prognostic Factors of N2 Stage Non-small Cell Lung Cancer after Surgery].

Yang Z, Wei S, Xia L, Liu L. Yang Z, et al. Zhongguo Fei Ai Za Zhi. 2020 Jan 20;23(1):15-20. doi: 10.3779/j.issn.1009-3419.2020.01.03. Zhongguo Fei Ai Za Zhi. 2020. PMID: 31948533 Free PMC article. Chinese.

7

Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer.

Yang Z, Wei S, Liu L. Yang Z, et al. JAMA Oncol. 2020 Apr 1;6(4):587. doi: 10.1001/jamaoncol.2019.6865. JAMA Oncol. 2020. PMID: 32077898 No abstract available.

8

Clinical significance of tumour mutation burden in immunotherapy across multiple cancer types: an individual meta-analysis.

Yang Z, Wei S, Deng Y, Wang Z, Liu L. Yang Z, et al. Jpn J Clin Oncol. 2020 Sep 5;50(9):1023-1031. doi: 10.1093/jjco/hyaa076. Jpn J Clin Oncol. 2020. PMID: 32542383

9

LncAS2Cancer: a comprehensive database for alternative splicing of lncRNAs across human cancers.

Deng Y, Luo H, Yang Z, Liu L. Deng Y, et al. Among authors: yang z. Brief Bioinform. 2021 May 20;22(3):bbaa179. doi: 10.1093/bib/bbaa179. Brief Bioinform. 2021. PMID: 32820322

10

ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer.

Liu Z, Zhao K, Wei S, Liu C, Zhou J, Gou Q, Wu X, Yang Z, Yang Y, Peng Y, Cheng Q, Liu L. Liu Z, et al. Among authors: yang y, yang z. Oncoimmunology. 2020 May 6;9(1):1758003. doi: 10.1080/2162402X.2020.1758003. Oncoimmunology. 2020. PMID: 32923114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,892 results

Search Page

Filters